GlassScriptPhysician profile
Amy N Moore
NPI 1881694073
$574.25
in general payments reported to CMS, 2019-2025
11 companies · $100 in 2025
The $100 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $219 · 2023: $173 · 2024: $81.82 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $108.81 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.41 | 2023 | |
| Evofem Biosciences, INC. | $65.83 | 2022-2024 | Phexxi |
| Organon LLC | $63.40 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $54.69 | 2022-2025 | Slynd |
| Biogen, INC. | $45.68 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $35.59 | 2025 | Thinprep 2000 Processor |
| Avion Pharmaceuticals | $35.26 | 2022-2023 | Balcoltra |
| Pfizer INC. | $30.68 | 2022 | |
| Kci USA, INC. | $21.67 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.23 | 2023 | Nuedexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.